Twitter | Search | |
Neth. Cancer Inst.
The Netherlands Cancer Institute (NKI): for more than 100 years at the international forefront of cancer research and treatment. Our Dutch account is .
413
Tweets
852
Following
1,676
Followers
Tweets
Neth. Cancer Inst. retweeted
@EULIFEnews Apr 1
We are deeply sad by the passing away of Michael Wakelam, Director of and member of EU-LIFE Board of Directors. Michael was a great friend and colleague who will be terribly missed. All our thoughts are with his family and Babraham Institute community.
Reply Retweet Like
Neth. Cancer Inst. Apr 2
This is very sad news. Our deepest condolences to Michael's family and friends and to all our colleagues from Babraham Institute. Our thoughts are with you.
Reply Retweet Like
Neth. Cancer Inst. Mar 24
Drug repurposing is an effective approach to rapidly identify new indications for known drugs and compounds. To support researchers in bringing therapeutic applications to the patient at affordable costs now has a new kind of library. ⬇️
Reply Retweet Like
Neth. Cancer Inst. retweeted
van Rheenen Lab Mar 18
Our paper on how the effects of a T cell extend beyond its targets got published last week ! A great collaboration with Ton Schumacher's lab Congratulations to Laura, Mirjam and all the co-authors!
Reply Retweet Like
Neth. Cancer Inst. Mar 2
Replying to @KellyDeLigt @hetAVL
Hi Kelly wat leuk! Welkom en een mooie interessante tijd gewenst bij ons!🍀
Reply Retweet Like
Neth. Cancer Inst. Mar 2
Replying to @dvdstelt @BelMeNiet
Hi Dennis, wat vervelend. Het klinkt niet als iets voor ons. We bellen namelijk sinds 1 oktober 2019 in het hele instituut niet meer anoniem. Geef de persoon die belt aan dat zij van het AVL of NKI zijn? We willen graag meer weten. DM?
Reply Retweet Like
Neth. Cancer Inst. retweeted
J Cell Science Feb 27
The final 'First person' interview in this Issue is with Fernando Salgado-Polo on his PhD project in the lab investigating the role of (lyso)phospholipases in cell signaling:
Reply Retweet Like
Neth. Cancer Inst. retweeted
Wouter Moolenaar Feb 27
is an intriguing enzyme on the surface of nerve cells, where it protects against progressive . Fernando’s paper describes the dynamic recycling of GDE2 from and to the cell surface, of potential relevance for neurodegenerative disease.
Reply Retweet Like
Neth. Cancer Inst. retweeted
Oncode Institute Feb 13
65 clinicians, fundamental scientists, clinical scientists and industry joined Oncode's clinical workshop on breast cancer yesterday to discuss clinical needs, challenges and opportunities in the breast cancer field. Thanks to all speakers and participants for a great evening!
Reply Retweet Like
Neth. Cancer Inst. retweeted
Medicine Matters oncology Feb 12
This week's top story: Antibiotics, PPIs may adversely affect outcomes in . Study by () & colleagues reported in . Click through for our report
Reply Retweet Like
Neth. Cancer Inst. retweeted
@EULIFEnews Jan 28
📣We are ! We are looking for a & to join team. A great opportunity to work on an international alliance 🇪🇺🧪 Based in Barcelona. Learn more & apply➡️
Reply Retweet Like
Neth. Cancer Inst. retweeted
Ursula von der Leyen Feb 4
Launch of Europe's Beating Cancer Plan Watch live 📺🔽
Reply Retweet Like
Neth. Cancer Inst. retweeted
Mariya Gabriel Feb 4
Key to fighting : boosting R&I into more knowledge, better prevention, optimised care, better survivor life quality. On find out more about the :
Reply Retweet Like
Neth. Cancer Inst. Feb 4
Research led by Lisette Rozeman was selected by the American Society of Clinical Oncology for inclusion in the Clinical Cancer Advances 2020, which highlights the most impactful research advances of the past year. :
Reply Retweet Like
Neth. Cancer Inst. retweeted
Suz Jan 24
I am very honored to receive the NVE 2019 best thesis award! Thank you very much to my supervisors & outstanding colleagues who made it possible!
Reply Retweet Like
Neth. Cancer Inst. Jan 27
How can physicians optimally treat patients with pyrimidine analogues? PhD student Ellen Derissen investigated to what extend those medicines manage to get into the patients' cells and be activated once arrived. Good luck! 👩‍🎓
Reply Retweet Like
Neth. Cancer Inst. Jan 20
The development of new drugs to treat cancer has increased significantly. Many of the newly developed targeted drugs are administered orally, causing an increased variability in drug levels and exposure compared to intravenously administered drugs. 👩‍🎓
Reply Retweet Like
Neth. Cancer Inst. Jan 16
Lisette Rozeman has won the 2019 award for her excellent research into immunotherapy for melanoma patients. She examined how doctors could use immunotherapy in even more effective ways to fight cancer in these patients. Read the full article here:
Reply Retweet Like
Neth. Cancer Inst. retweeted
Mass General Research Institute Jan 14
Fleur Jochems of and slams on her investigating a new two-step strategy, like a one-two punch, to treat !
Reply Retweet Like
Neth. Cancer Inst. retweeted
Oncode Institute Jan 10
In 2020, Oncode will continue to organize clinical workshops. The next one will focus on breast cancer and is chaired by Oncode Investigator Jos Jonkers and oncologist Agnes Jager . Info on speakers, program & registration via:
Reply Retweet Like